Lipocine Investments vs Property Plant and Equipment Net Analysis
LPCN Stock | USD 4.44 0.36 7.50% |
Lipocine financial indicator trend analysis is infinitely more than just investigating Lipocine recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lipocine is a good investment. Please check the relationship between Lipocine Investments and its Property Plant And Equipment Net accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
Investments vs Property Plant And Equipment Net
Investments vs Property Plant and Equipment Net Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lipocine Investments account and Property Plant and Equipment Net. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Lipocine's Investments and Property Plant and Equipment Net is 0.42. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Property Plant and Equipment Net in the same time period over historical financial statements of Lipocine, assuming nothing else is changed. The correlation between historical values of Lipocine's Investments and Property Plant and Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of Lipocine are associated (or correlated) with its Property Plant and Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant and Equipment Net has no effect on the direction of Investments i.e., Lipocine's Investments and Property Plant and Equipment Net go up and down completely randomly.
Correlation Coefficient | 0.42 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most indicators from Lipocine's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lipocine current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.At this time, Lipocine's Selling General Administrative is very stable compared to the past year. As of the 24th of April 2024, Sales General And Administrative To Revenue is likely to grow to 46.82, while Tax Provision is likely to drop 411.40.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 5.3M | 4.1M | 15.1M | 15.8M | Cost Of Revenue | 7.7M | 8.6M | 28.7K | 27.2K |
Lipocine fundamental ratios Correlations
Click cells to compare fundamentals
Lipocine Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lipocine fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 19.7M | 25.4M | 52.5M | 37.5M | 23.0M | 29.7M | |
Other Current Liab | 449.3K | 1.7M | 1M | 1.1M | 1.2M | 1.5M | |
Total Current Liabilities | 5.0M | 6.6M | 5.6M | 1.7M | 2.6M | 3.4M | |
Total Stockholder Equity | 6.3M | 15.3M | 45.6M | 35.6M | 20.4M | 24.6M | |
Net Debt | (2.6M) | (13.6M) | (639.7K) | (3.1M) | (4.8M) | (5.0M) | |
Retained Earnings | (151.1M) | (172.0M) | (172.7M) | (183.4M) | (199.8M) | (189.8M) | |
Accounts Payable | 1.2M | 1.6M | 1.3M | 600.4K | 1.4M | 798.8K | |
Cash | 9.7M | 19.2M | 3.0M | 3.1M | 4.8M | 9.2M | |
Cash And Short Term Investments | 14.1M | 19.7M | 44.6M | 32.5M | 22.0M | 26.6M | |
Common Stock Total Equity | 2.2K | 3.8K | 7.0K | 8.8K | 10.2K | 10.7K | |
Common Stock Shares Outstanding | 1.5M | 3.3M | 5.1M | 5.2M | 5.3M | 5.5M | |
Liabilities And Stockholders Equity | 19.7M | 25.4M | 52.5M | 37.5M | 23.0M | 29.7M | |
Other Current Assets | 545.9K | 661.3K | 1.5M | 945.3K | 773.4K | 1.0M | |
Other Stockholder Equity | 157.4M | 187.4M | 218.2M | 219.1M | 220.1M | 147.6M | |
Total Liab | 13.4M | 10.0M | 6.9M | 1.9M | 2.6M | 5.1M | |
Total Current Assets | 19.6M | 25.3M | 46.4M | 34.1M | 22.9M | 28.8M | |
Accumulated Other Comprehensive Income | (963.0) | (38.0) | (18.0K) | (20.3K) | 7.3K | 7.6K | |
Common Stock | 3.8K | 7.0K | 8.8K | 8.9K | 8.9K | 9.3K | |
Property Plant Equipment | 19.0K | 3.6K | 7.2K | 131.6K | 118.4K | 124.4K | |
Net Tangible Assets | 6.3M | 15.3M | 45.6M | 35.6M | 41.0M | 27.0M | |
Retained Earnings Total Equity | (138.1M) | (151.1M) | (172.0M) | (172.7M) | (155.4M) | (163.2M) | |
Short Term Investments | 4.3M | 450.0K | 41.7M | 29.4M | 17.3M | 15.1M | |
Capital Surpluse | 147.5M | 157.4M | 187.4M | 218.3M | 251.0M | 143.4M | |
Property Plant And Equipment Net | 3.6K | 0.0 | 7.2K | 131.6K | 116.1K | 63.4K | |
Non Current Assets Total | 27.3K | 23.8K | 6.1M | 3.4M | 139.8K | 132.9K | |
Property Plant And Equipment Gross | 3.6K | 1.1M | 1.2M | 1.3M | 1.3M | 1.4M | |
Net Receivables | 16.5K | 391.0 | 247.3K | 659.9K | 52.3K | 49.6K | |
Net Invested Capital | 13.4M | 20.9M | 47.9M | 35.6M | 20.4M | 27.8M | |
Net Working Capital | 14.7M | 18.7M | 40.8M | 32.5M | 20.2M | 25.5M | |
Short Long Term Debt Total | 7.1M | 5.6M | 2.3M | 17.2K | 15.4K | 14.7K | |
Capital Stock | 3.8K | 7.0K | 8.8K | 8.9K | 8.9K | 7.2K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lipocine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lipocine's short interest history, or implied volatility extrapolated from Lipocine options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.